NeuroOne Medical Technologies Q2 2024 Earnings Report $0.86 -0.01 (-1.13%) As of 04:00 PM Eastern Earnings History NeuroOne Medical Technologies EPS ResultsActual EPS-$0.11Consensus EPS N/ABeat/MissN/AOne Year Ago EPSN/ANeuroOne Medical Technologies Revenue ResultsActual Revenue$1.38 millionExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/ANeuroOne Medical Technologies Announcement DetailsQuarterQ2 2024Date5/14/2024TimeN/AConference Call ResourcesNMTC Earnings History Remove Ads NeuroOne Medical Technologies Earnings HeadlinesBrainsWay (NASDAQ:BWAY) & NeuroOne Medical Technologies (NASDAQ:NMTC) Head to Head SurveyMarch 31 at 2:21 AM | americanbankingnews.comNeuroOne Medical Technologies CEO Discusses Epilepsy Treatment Advances and OneRF® Ablation System on Today’s MarketplaceMarch 20, 2025 | nasdaq.comElon Musk is helping print “new gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest breakthrough in artificial intelligence… but in human technology. It’s so valuable that some are referring to it as the “new gold”.April 2, 2025 | True Market Insiders (Ad)NeuroOne CEO Discusses Breakthrough OneRF System For Epilepsy Treatment On Today's MarketplaceMarch 20, 2025 | nasdaq.comNeuroOne® CEO Dave Rosa Discusses Epilepsy Treatment Innovations on Today’s Marketplace - UpdateMarch 18, 2025 | markets.businessinsider.comNeuroOne® CEO Dave Rosa Discusses Epilepsy Treatment Innovations on Today's Marketplace - UpdateMarch 18, 2025 | globenewswire.comSee More NeuroOne Medical Technologies Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like NeuroOne Medical Technologies? Sign up for Earnings360's daily newsletter to receive timely earnings updates on NeuroOne Medical Technologies and other key companies, straight to your email. Email Address About NeuroOne Medical TechnologiesNeuroOne Medical Technologies (NASDAQ:NMTC), a developmental stage company, provides solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other related neurological disorders. It also fucuses on applications for other areas, such as depression, mood disorders, pain, incontinence, high blood pressure, and artificial intelligence. It has a strategic partnership with RBC Medical Innovations to develop a radio frequency ablation generator. The company was incorporated in 2009 and is based in Eden Prairie, Minnesota.View NeuroOne Medical Technologies ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Intuitive Machines Gains After Earnings Beat, NASA Missions AheadCintas Delivers Earnings Beat, Signals More Growth AheadNike Stock Dips on Earnings: Analysts Weigh in on What’s NextAfter Massive Post Earnings Fall, Does Hope Remain for MongoDB?Semtech Rallies on Earnings Beat—Is There More Upside?These 3 Q1 Earnings Winners Will Go HigherWhat Is the Price-to-Earnings (P/E) Ratio? Upcoming Earnings Bank of New York Mellon (4/11/2025)BlackRock (4/11/2025)JPMorgan Chase & Co. (4/11/2025)Progressive (4/11/2025)Wells Fargo & Company (4/11/2025)Interactive Brokers Group (4/15/2025)Bank of America (4/15/2025)Citigroup (4/15/2025)Johnson & Johnson (4/15/2025)Morgan Stanley (4/15/2025) Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
